Viewing Study NCT03802604


Ignite Creation Date: 2025-12-24 @ 9:08 PM
Ignite Modification Date: 2026-01-01 @ 5:00 PM
Study NCT ID: NCT03802604
Status: COMPLETED
Last Update Posted: 2025-09-09
First Post: 2018-11-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Combination of Talimogene Laherparepvec With Atezolizumab in Early Breast Cancer
Sponsor: SOLTI Breast Cancer Research Group
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module